Aging is a part of life that we can't do anything about, but we can slow it down or speed it up depending on our lifestyle choices and health habits. In addition to prematurely aging, certain health issues can arise causing the process to accelerate and Eat This, Not That! Health spoke with experts who share signs you're aging faster than you should that you need to be aware of
Author Archives: admin
Complicated Urinary Tract Infections Market to Witness Growth at a CAGR of 5.9% by 2032 | DelveInsight – PR Newswire
The dynamics of the complicated urinary tract infection market are anticipated to change in the coming years owing to the improvement in the rise in the number of healthcare spending across the world and rising cases of complicated urinary tract infection.
Triple-Negative Breast Cancer Treatment Market to Experience Significant Growth During the Forecast Period 2026 – BioSpace
Wilmington, Delaware, United States, Transparency Market Research Inc. Triple-negative breast cancer (TNBC) doesnt have estrogen or progesterone receptors and also doesnt make too much of the HER2 protein
Amolyt Pharma Announces Positive Efficacy and Safety Data from First Cohort of Phase 2a Study of AZP-3601 in Patients with Hypoparathyroidism at the…
- Company to host Key Opinion Leader webinar today, September 12, at 1:30 pm CT/2:30 pm ET - LYON, France and CAMBRIDGE, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, today announced positive efficacy and safety data from the first cohort of its ongoing Phase 2a study of AZP-3601 in patients with hypoparathyroidism at the American Society for Bone and Mineral Research 2022 Annual Meeting (ASBMR), which is being held September 9-12 in Austin, TX.
Like it or not, e-bikes on Hilton Head are here – Charleston Post Courier
HILTON HEAD ISLANDPeople move to Hilton Head for all kinds of reasons.
Ribociclib Can Add Almost 1 Year to Overall Survival for Patients With Aggressive Form of Breast Cancer – Pharmacy Times
Ribociclib with endocrine therapy was found to increase the median overall survival of patients with HR+/HER2- advanced breast cancer with visceral metastases to nearly 5 years. Ribociclib (Kisqali; Novartis) was found to add nearly 1 year to overall survival (OS) in patients with aggressive hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer (aBC). In a pooled exploratory analysis of the MONALEESA phase 3 program presented at the 2022 European Society of Medical Oncology Congress (ESMO), researchers found that first-line treatment with ribociclib and endocrine therapy increased the median OS by 10.6 months, compared to endocrine therapy alone.
Discover the Mental and Physical Health Benefits of Fasting – Intelligent Living
Healthy fasting is therapeutic if appropriately done, and evidence supports this. Our body can cure itself if given the correct nourishment, movement, sleep, emotional wellness, and surroundings; fasting boosts its curing capabilities. Its vital for holistic health.
Biosimilars Global Market Opportunities and Strategies Report 2022: Long-term Forecast to 2026 & 2031 – ResearchAndMarkets.com – Business Wire
DUBLIN--(BUSINESS WIRE)--The "Biosimilars Global Market Opportunities And Strategies To 2031" report has been added to ResearchAndMarkets.com's offering. The global biosimilars market reached a value of nearly $11,418.9 million in 2021, having grown at a compound annual growth rate (CAGR) of 34.8% since 2016. The market is expected to grow from $11,418.9 million in 2021 to $25,985.2 million in 2026 at a rate of 17.3%
Lumos Pharma to Participate in the HC Wainwright 24th Annual Global Investment Conference – GuruFocus.com
AUSTIN, Texas, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (LUMO, Financial), a biopharmaceutical company advancing a novel oral therapeutic candidate, LUM-201, through Phase 2 clinical trials for Pediatric Growth Hormone Deficiency (PGHD), announced that the Company will present and host one-on-one meetings at the H.C
The Global External Fixation Systems Market to Witness Growth at a CAGR of 5.62% During the Study Period (20192027) | DelveInsight – Yahoo Finance
DelveInsight Business Research LLP The external fixation systems market is anticipated to surge due to the factors such as the increasing prevalence of degenerative bone disorders such as osteoporosis and osteoarthritis. Another prominent factor contributing to product demand growth is the surge in the global increase in the geriatric population base, who form a major section of the patient pool of fractures due to frequent falls and degenerative bone diseases. The increasing focus on product development activities with the latest innovation with respect to external fixators also plays a key role in establishing a positive growth trend in the external fixation systems market during the forecast period from 2022 to 2027.